Find out everything our Platform Partners have been up to in the last quarter!

Early lung cancer diagnosis and reporting partner, Aidence, launched a new study called INPACT which will be used jointly with their research partners and aim to provide results by the end of 2022 – this study aims to understand if radiologists make better decisions with AI. Their co-founder, Jeroen van Duffelen, also published a very interesting article explaining why the algorithm is only a fraction of the work when it comes to medical devices. The biggest news for Aidence in this last quarter as been their acquisition by RadNet, ‘a national leader in high-quality, cost-effective, fixed-site outpatient diagnostic imaging services’ which is a big step towards accelerating AI solutions for the oncology pathway.

The AI companion for bone trauma and lesion detection on chest-Xrays, Gleamer, have recently published an article in Skeletal Radiology showing the value of BoneView for Pediatric exams (valid for CE customer, not yet FDA validated on Pediatric).

Computer aided diagnostics company Azmed have announced they have ‘received U.S. Food and Drug Administration (FDA) clearance for its AI diagnostic tool called « Rayvolve » capable of detecting fractures on standard X-Rays’.

And finally, visualization and analytical solutions developer Imaging Biometrics submitted an FDA application for an AI application that generates a T1+C image without using any contrast (gadolinium).

 Stay tuned for more partner news next month!